Literature DB >> 1104748

A mechanism for the induction of immunological tolerance by antigen feeding: antigen-antibody complexes.

C André, J F Heremans, J P Vaerman, C L Cambiaso.   

Abstract

We have previously reported on the induction, in mice, of a systemic (splenic) immune response with IgA as the dominant antibody, as a result of a short (4 day) intragastric immunization course with foreign erythrocytes. This response was followed by a prolonged period of hyporesponsiveness to similarly administered antigen. Here it is shown that this hyporesponsiveness is also manifested towards antigen given intraperitoneally, and that one is therefore dealing with tolerance, not with failure to absorb antigen from the gut. In contrast, mice primed parenterally and then challenged intragastrically behaved as if never having any previous contact with the antigen, i.e., with a primary-type splenic response of predominant IgA character. This agrees with our former conclusion that splenic responses to enterically absorbed antigen reflect colonization of the spleen by cells sensitized locally in the gut wall, a site not readily primed by the parenteral route. Serum from intragastrically immunized mice contained a very active tolerogen. In vivo, it was capable of conferring tolerance to nonimmune recipient mice. In vitro, it paralyzed the activity of antibody-producing cells. Inhibitory sera has weak antibody activity, restricted to the IgA class, and contained immune complexes reacting with rheumatoid factor but not with C1q. Elimination of these complexes by means by insolubilized rheumatoid factor abolished the tolerogenic effect. In conclusion, the enterically induced tolerogen seems to consist of immune complexes with IgA as the antibody.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1104748      PMCID: PMC2190065          DOI: 10.1084/jem.142.6.1509

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  INDUCTION OF IMMUNOLOGICAL PARALYSIS IN TWO ZONES OF DOSAGE.

Authors:  N A MITCHISON
Journal:  Proc R Soc Lond B Biol Sci       Date:  1964-12-15

2.  THE ANTIGENICITY OF AGGREGATED AND AGGREGATE-FREE HUMAN GAMMA-GLOBULIN FOR RABBITS.

Authors:  C E BIRO; G GARCIA
Journal:  Immunology       Date:  1965-04       Impact factor: 7.397

3.  Immunological unresponsiveness produced in adult guinea pigs by parenteral introduction of minute quantities of hapten or protein antigen.

Authors:  J R BATTISTO; J MILLER
Journal:  Proc Soc Exp Biol Med       Date:  1962-10

4.  Tolerance to heterologous erythrocytes.

Authors:  R Auerbach; J Roethle
Journal:  Science       Date:  1974-01-25       Impact factor: 47.728

5.  Influence of repeated administration of antigen by the oral route on specific antibody-producing cells in the mouse spleen.

Authors:  C André; H Bazin; J F Heremans
Journal:  Digestion       Date:  1973       Impact factor: 3.216

6.  Mesenteric lymph as a major source of serum IgA in guinea pigs and rats.

Authors:  J P Vaerman; C André; H Bazin; J F Heremans
Journal:  Eur J Immunol       Date:  1973-09       Impact factor: 5.532

7.  Interference of oral immunization with the intestinal absorption of heterologous albumin.

Authors:  C André; R Lambert; H Bazin; J F Heremans
Journal:  Eur J Immunol       Date:  1974-10       Impact factor: 5.532

8.  Intestinal uptake of macromolecules: effect of oral immunization.

Authors:  W A Walker; K J Isselbacher; K J Bloch
Journal:  Science       Date:  1972-08-18       Impact factor: 47.728

9.  Effector cell blockade. A new mechanism of immune hyporeactivity induced by multivalent antigens.

Authors:  J W Schrader; G J Nossal
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

10.  Antibodies of the IgA type in intestinal plasma cells of germfree mice after oral or parenteral immunization with ferritin.

Authors:  P A Crabbé; D R Nash; H Bazin; D V Eyssen; J F Heremans
Journal:  J Exp Med       Date:  1969-10-01       Impact factor: 14.307

View more
  42 in total

1.  Effect of vitamin A on the systemic and local antibody responses to intragastrically administered bovine serum albumin.

Authors:  K R Falchuk; W A Walker; J L Perrotto; K J Isselbacher
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

Review 2.  The intestinal immune system.

Authors:  W F Doe
Journal:  Gut       Date:  1989-12       Impact factor: 23.059

3.  Induction of oral tolerance in rats without Peyer's patches.

Authors:  G Enders; T Gottwald; W Brendel
Journal:  Immunology       Date:  1986-06       Impact factor: 7.397

4.  The immune response of mice to bacterial antigens given by mouth.

Authors:  C R Stokes; T J Newby; J H Huntley; D Patel; F J Bourne
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

5.  Cimetidine prevents the induction of unresponsiveness by feeding T-dependent antigens.

Authors:  M Pinto; H Herzberg
Journal:  Experientia       Date:  1981-05-15

6.  IgE and IgG1 antibody production by a soluble product of Ascaris suum in the guinea-pig.

Authors:  B E Stromberg
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

Review 7.  Evidence of immunoregulation of the composition of intestinal microflora and its practical consequences.

Authors:  D van der Waaij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

8.  Study of autoimmune response to rat male accessory glands in rats born to immune mothers.

Authors:  M C Pistoresi-Palencia; C M Riera; M Galmarini; E Vottero-Cima; H M Serra
Journal:  Immunology       Date:  1984-09       Impact factor: 7.397

9.  IgE antibody suppression following aerosol exposure to antigens.

Authors:  P C Fox; R P Siraganian
Journal:  Immunology       Date:  1981-06       Impact factor: 7.397

10.  Effective immunity to dental caries: dose-dependent studies of secretory immunity by oral administration of Streptococcus mutans to rats.

Authors:  S M Michalek; J R McGhee; J L Babb
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.